Cited 102 time in
2-Methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hwa, Jeong Seok | - |
| dc.contributor.author | Jin, Yong Chun | - |
| dc.contributor.author | Lee, Young Soo | - |
| dc.contributor.author | Ko, Young Shin | - |
| dc.contributor.author | Kim, Young Min | - |
| dc.contributor.author | Shi, Lian Yu | - |
| dc.contributor.author | Kim, Hye Jung | - |
| dc.contributor.author | Lee, Jae Heun | - |
| dc.contributor.author | Tran Minh Ngoc | - |
| dc.contributor.author | Bae, Ki Hwan | - |
| dc.contributor.author | Kim, Yeong Shik | - |
| dc.contributor.author | Chang, Ki Churl | - |
| dc.date.accessioned | 2022-12-27T01:56:11Z | - |
| dc.date.available | 2022-12-27T01:56:11Z | - |
| dc.date.issued | 2012-01-31 | - |
| dc.identifier.issn | 0378-8741 | - |
| dc.identifier.issn | 1872-7573 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/22378 | - |
| dc.description.abstract | Ethnopharmacological relevance: Cinnamomum cassia Blume has been used as a traditional Chinese herbal medicine for alleviation of fever, inflammation, chronic bronchitis, and to improve blood circulation. Aim of the study: We addressed whether 2-methoxycinnamaldehyde (2-MCA), one of active ingredients of Cinnamomum cassia, reduces vascular cell adhesion molecule-1 (VCAM-1) expression in tumor necrosis factor-alpha (TNF-alpha)-activated endothelial cells and protects ischemia/reperfusion (I/R)-injury due to heme oxygenase (HO)-1 induction. Materials and methods: Adult male rats were subjected to 30 min of ischemia by occlusion of the left anterior descending coronary artery followed by 24 h of reperfusion. Rats were randomized to receive vehicle or 2-MCA (i.v.) 10 min before reperfusion. Results: Administration of 2-MCA significantly improved I/R-induced myocardial dysfunction by increasing the values of the first derivative (+/- dp/dr) of left ventricular pressure and decreased infarct size. In addition, 2-MCA reduced the expression of high mobility group box 1 (HMGB1), an activator of the inflammatory cascade when released into the extracellular space, and VCAM-1 in I/R myocardium along with increase of HO-1 induction. The reduced injury was accompanied by significantly reduction of neutrophils infiltration and increased SOD activity in ischemic tissues and reduced serum level of cardiac troponin I (cTnl). Furthermore, 2-MCA significantly increased HO-1 induction by translocation of Nrf-2 from cytosol to nucleus in endothelial cells. Inhibition of VCAM-1 expression by 2-MCA was reversed both by SnPPIX, a HO-1 inhibitor and siHO-1 RNA trasfection in TNF-alpha-activated cells. In addition, 2-MCA significantly inhibited NF-kappa B luciferase activity in TNF-alpha-activated endothelial cells. As expected, 2-MCA significantly inhibited monocyte (U937) adhesion to endothelial cells. Conclusion: We concluded that 2-MCA protects of myocardial I/R-injury due to antioxidant and anti-inflammatory action possibly by HO-1 induction which can be explained why Cinnamomum cassia has been used in inflammatory disorders. (C) 2011 Elsevier Ireland Ltd. All rights reserved. | - |
| dc.format.extent | 11 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER IRELAND LTD | - |
| dc.title | 2-Methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction | - |
| dc.type | Article | - |
| dc.publisher.location | 아일랜드 | - |
| dc.identifier.doi | 10.1016/j.jep.2011.12.001 | - |
| dc.identifier.scopusid | 2-s2.0-84856013387 | - |
| dc.identifier.wosid | 000302505900039 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF ETHNOPHARMACOLOGY, v.139, no.2, pp 605 - 615 | - |
| dc.citation.title | JOURNAL OF ETHNOPHARMACOLOGY | - |
| dc.citation.volume | 139 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 605 | - |
| dc.citation.endPage | 615 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Plant Sciences | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
| dc.relation.journalWebOfScienceCategory | Plant Sciences | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | ALPHA-INDUCED EXPRESSION | - |
| dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
| dc.subject.keywordPlus | KAPPA-B ACTIVATION | - |
| dc.subject.keywordPlus | HEME OXYGENASE-1 | - |
| dc.subject.keywordPlus | ADHESION MOLECULES | - |
| dc.subject.keywordPlus | FREE-RADICALS | - |
| dc.subject.keywordPlus | CINNAMALDEHYDE | - |
| dc.subject.keywordPlus | CELL | - |
| dc.subject.keywordPlus | ISCHEMIA/REPERFUSION | - |
| dc.subject.keywordPlus | CONSTITUENTS | - |
| dc.subject.keywordAuthor | 2-Methoxycinnamaldehyde | - |
| dc.subject.keywordAuthor | Inflammation | - |
| dc.subject.keywordAuthor | HMGB1 | - |
| dc.subject.keywordAuthor | VCAM-1 | - |
| dc.subject.keywordAuthor | Heme oxygenase-1 | - |
| dc.subject.keywordAuthor | Ischemia | - |
| dc.subject.keywordAuthor | Reperfusion injury | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
